MARATTO

article · Journal of Toxicology

Evaluation of Skin Irritation and Acute and Subacute Oral Toxicity of<i> Lavandula angustifolia</i> Essential Oils in Rabbit and Mice

201958 citationsOpen accessDebre Berhan University

In plain language

Essential oil from Lavandula angustifolia, traditionally used in Ankober District in North Central Ethiopia to treat human and livestock ailments, was evaluated for safety. Chemical analysis revealed eucalyptol as the primary constituent at 52.36 percent, alongside camphor, gamma-terpinene, and endoborneol. In animal testing, an acute oral limit test in mice established a lethal dose higher than 2000 mg/kg. Repeated oral administration of 2000 mg/kg daily for 21 days in mice produced no significant alterations in body weight, food and water consumption, biochemical measures, gross morphology, or liver and kidney tissue structure. In addition, topical application of a 10 percent essential oil ointment showed no skin irritation. Overall, the investigations demonstrated that the essential oil is non-toxic under the evaluated conditions.

Key takeaways

  • Chemical profiling identified eucalyptol (52.36 percent) and camphor (11.91 percent) as the dominant constituents in Lavandula angustifolia essential oil.
  • Acute oral toxicity testing in mice revealed a lethal dose value greater than 2000 mg/kg.
  • Subacute oral administration of 2000 mg/kg over 21 days caused no significant changes in body weight, biochemical markers, or kidney and liver histopathology in mice.
  • Topical application of a 10 percent ointment formulation produced no skin irritation.

Why it matters

Traditional botanical remedies require formal safety verification before broader healthcare or veterinary adoption. By establishing that Lavandula angustifolia essential oil does not cause acute oral toxicity, organ damage, or skin irritation at the tested levels, this evaluation provides baseline preclinical toxicological evidence to support its traditional medicinal use for treating humans and livestock.

Commercialisation angle

The findings offer preliminary safety data relevant to developers of herbal medicines, veterinary treatments, or topical formulations containing Lavandula angustifolia essential oil. Because this research represents early-stage animal toxicity testing, considerable further investigation, including human clinical trials and product formulation, would be required before commercial market entry.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Lavandula angustifolia is used in traditional and folk medicines of Ankober District, North Central Ethiopia, for the treatment of several livestock and human disorders. This toxicity study aimed to investigate L. angustifolia essential oil oral toxicity in mice and skin irritation in rabbit. L. angustifolia essential oil was analyzed using gas chromatography-mass spectrometry methods and showed predominance of Eucalyptol (52.36%), Camphor (11.91%), gamma-terpinene (8.775%) and endoborneol (7.585%). Limit test at 2000 mg/kg dose was used for L. angustifolia essential oil acute toxicity test and revealed LD 50 value was higher than 2000 mg/kg. For subacute toxicity study 2000mg/kg was given orally to each mouse for 21 days. The result demonstrated no significant changes (p &gt; 0.05) in the body weights, and biochemical parameters, gross abnormalities, water, and food intake were observed. No macroscopic changes were seen in the histopathology analysis of kidneys and livers. For skin irritation test shaved rabbit skin was treated with 10% ointment formulation. Ointment of L. angustifolia oil did not affect mice skin. Generally, this toxicity study demonstrated that L. angustifolia essential oil is nontoxic.

Research topics

  • Essential Oils and Antimicrobial Activity
  • Ethnobotanical and Medicinal Plants Studies
  • Botanical Research and Chemistry

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1155/2019/5979546

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.